Post-IPO Equity - Greenlight Biosciences
Investment Firm
Overview
GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.
Announced Date
Feb 03, 2022
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
14
Round Details and Background
Greenlight Biosciences raised $125500000 on 2022-02-03 in Post-IPO Equity
GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.
Company Funding History
10
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 20, 2013 |  Series A - Greenlight Biosciences | - | 1.0M | |
| Jul 22, 2015 | Series C - Greenlight Biosciences | 1 | - | undefined |
| Jun 17, 2015 | Series B - Greenlight Biosciences | - | 20.0M | |
| Aug 12, 2013 | Series A - Greenlight Biosciences | 2 | - | 7.0M |
Recent Activity
There is no recent news or activity for this profile.